4.8 Article

Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, Research & Experimental

Overcoming innate immune barriers that impede AAV gene therapy vectors

Manish Muhuri et al.

Summary: Research has shown that host immune responses against rAAVs have hindered the progress of gene therapy. Both the innate and adaptive arms of the immune system play a role in this response.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biotechnology & Applied Microbiology

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian R. Long et al.

Summary: The evaluation of immune responses before and after AAV-mediated gene therapy plays a key role in determining therapeutic safety and efficacy. This study found that administration of BMN 270 mainly led to antibodies against the AAV5 capsid, with no FVIII inhibitor responses observed within 3 years of treatment.

MOLECULAR THERAPY (2021)

Review Cell Biology

MicroRNA-99 family in cancer and immunity

Joseph Eniafe et al.

Summary: The miR-99 family is a conserved group of miRs with dual roles as oncogenic miRs and tumor suppressing miRs in different types of cancer. In addition to their roles in cancer, they also play critical roles in regulating inflammatory responses and T-cell subsets.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)

Article Medicine, General & Internal

Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis

Eleni Chouri et al.

Summary: The study found that miRNA expression levels are altered in pDCs of early-stage SSc patients and may contribute to the observed pDC activation in patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Viral vector platforms within the gene therapy landscape

Jote T. Bulcha et al.

Summary: The field of gene therapy has made significant progress in combating human diseases and providing hope to patients and families with limited treatment options, but it has also faced setbacks. Viral-based vectors have played a crucial role in developing powerful drug platforms, but challenges still limit their full potential.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

miR-96-5p enhances cell proliferation and Invasion via targeted regulation of ZDHHC5 in gastric cancer

Baolong Wang et al.

BIOSCIENCE REPORTS (2020)

Review Immunology

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors

Giuseppe Ronzitti et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates

Benjamin J. Samelson-Jones et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Review Biotechnology & Applied Microbiology

Adeno-associated virus vector as a platform for gene therapy delivery

Dan Wang et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Medicine, Research & Experimental

miR-142 controls metabolic reprogramming that regulates dendritic cell activation

Yaping Sun et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Pharmacology & Pharmacy

Onasemnogene Abeparvovec: First Global Approval

Sheridan M. Hoy

Article Medicine, Research & Experimental

MicroRNA signature of regulatory T cells in health and autoimmunity

Mehdi Soltanzadeh-Yamchi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biotechnology & Applied Microbiology

miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6

Quanbo Ji et al.

MOLECULAR THERAPY (2018)

Review Medicine, Research & Experimental

Emerging Issues in AAV-Mediated In Vivo Gene Therapy

Pasqualina Colella et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Article Medicine, Research & Experimental

MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma

Bijay Dhungel et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Review Biotechnology & Applied Microbiology

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial

Celine Vandamme et al.

HUMAN GENE THERAPY (2017)

Article Biotechnology & Applied Microbiology

5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency

Christian Mueller et al.

MOLECULAR THERAPY (2017)

Article Multidisciplinary Sciences

Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency

Roberto Calcedo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

Article Cell Biology

MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation

Xiaoqin Jia et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)

Article Genetics & Heredity

The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer

Florence Boisgerault et al.

CURRENT GENE THERAPY (2015)

Article Medicine, Research & Experimental

MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis

Mireille Ouimet et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Medicine, General & Internal

Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis

J. W. B. Bainbridge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, Research & Experimental

The Status of RPE65 Gene Therapy Trials: Safety and Efficacy

Eric A. Pierce et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Article Hematology

MicroRNA 302a Is a Novel Modulator of Cholesterol Homeostasis and Atherosclerosis

Svenja Meiler et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

Article Medicine, General & Internal

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

A. C. Nathwani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

Cell-mediated immunity to AAV vectors, evolving concepts and potential solutions

Etiena Basner-Tschakarjan et al.

FRONTIERS IN IMMUNOLOGY (2014)

Editorial Material Biotechnology & Applied Microbiology

Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency

Anthony S. Wierzbicki et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2013)

Article Medicine, Research & Experimental

Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression

Christian Mueller et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Physiology

Nuclear positioning in muscle development and disease

Eric S. Folker et al.

FRONTIERS IN PHYSIOLOGY (2013)

Review Biochemistry & Molecular Biology

Gene therapy for lipoprotein lipase deficiency

Daniel Gaudet et al.

CURRENT OPINION IN LIPIDOLOGY (2012)

Article Endocrinology & Metabolism

Effect of Alipogene Tiparvovec (AAV1-LPLS447X) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients

Andre C. Carpentier et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Biotechnology & Applied Microbiology

MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression

Jun Xie et al.

MOLECULAR THERAPY (2011)

Article Biochemistry & Molecular Biology

AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins

A. Georgiadis et al.

GENE THERAPY (2010)

Article Medicine, General & Internal

Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.

Jerry R. Mendell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biotechnology & Applied Microbiology

Transduction of Nonhuman Primate Brain with Adeno-Associated Virus Serotype 1: Vector Trafficking and Immune Response

Piotr Hadaczek et al.

HUMAN GENE THERAPY (2009)

Article Multidisciplinary Sciences

Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals

Flavia Bazzoni et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Construction and analysis of compact muscle-specific promoters for AAV vectors

B. Wang et al.

GENE THERAPY (2008)

Review Cell Biology

Determination of T-cell fate by dendritic cells

Sandra S. Diebold

IMMUNOLOGY AND CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation

A. Rosa et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biotechnology & Applied Microbiology

Muscle as a target for supplementary factor IX gene transfer

Brad E. Hoffman et al.

HUMAN GENE THERAPY (2007)

Article Biotechnology & Applied Microbiology

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

Z Wang et al.

NATURE BIOTECHNOLOGY (2005)

Article Multidisciplinary Sciences

MicroRNAs modulate hematopoietic lineage differentiation

CZ Chen et al.

SCIENCE (2004)

Review Immunology

Central memory and effector memory T cell subsets: Function, generation, and maintenance

F Sallusto et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Article Immunology

Differential T cell function and fate in lymph node and nonlymphoid tissues

NL Harris et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2002)

Review Biochemistry & Molecular Biology

Dendritic cells: Specialized and regulated antigen processing machines

I Mellman et al.

Review Multidisciplinary Sciences

Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells

A Lanzavecchia et al.

SCIENCE (2000)